NCT00716547View on ClinicalTrials.gov

Safety and Efficacy of Two Dosages of Diractin® in Osteoarthritis (OA)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,399

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

May 31, 2009

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

ketoprofen in Diractin®

50 mg (b.i.d.)

DRUG

ketoprofen in Diractin®

100 mg (b.i.d.)

DRUG

Placebo

b.i.d.

DRUG

celecoxib

100 mg (b.i.d.)

Trial Locations (4)

65191

Klaus-Miehlke-Klinik, Wiesbaden

128 50

IDEA Investigational Site, Prague

87-100

NZOZ Nasz Lekarz, Torun

LS7 4SA

Chapel Allerton Hospital, Leeds

Sponsors

Lead Sponsor

IDEA AG
All Listed Sponsors
lead

IDEA AG

INDUSTRY